DocGo (NASDAQ:DCGO – Get Free Report)‘s stock had its “hold” rating reiterated by Canaccord Genuity Group in a note issued to investors on Tuesday,Benzinga reports. They presently have a $1.00 price objective on the stock. Canaccord Genuity Group’s price target points to a potential upside of 85.87% from the company’s previous close.
A number of other brokerages have also recently commented on DCGO. Needham & Company LLC restated a “buy” rating and issued a $3.00 price target on shares of DocGo in a research report on Tuesday. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a research report on Thursday, June 18th. Wall Street Zen upgraded shares of DocGo from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of DocGo in a report on Monday, May 11th. Three analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, DocGo has a consensus rating of “Hold” and an average target price of $2.38.
Check Out Our Latest Report on DocGo
DocGo Stock Down 24.2%
Institutional Trading of DocGo
Large investors have recently bought and sold shares of the business. Neuberger Berman Group LLC acquired a new stake in DocGo during the fourth quarter worth approximately $29,000. Cerity Partners LLC bought a new stake in DocGo in the second quarter worth approximately $37,000. Public Employees Retirement System of Ohio acquired a new position in DocGo in the fourth quarter valued at approximately $40,000. Engineers Gate Manager LP acquired a new position in DocGo in the second quarter valued at approximately $52,000. Finally, Diversify Advisory Services LLC bought a new position in shares of DocGo during the 2nd quarter worth approximately $53,000. 56.44% of the stock is currently owned by institutional investors and hedge funds.
DocGo Company Profile
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
Featured Articles
- Five stocks we like better than DocGo
- RTX Stock Gets a Radar Lock on a $23B Navy Win
- Berkshire Just Made a Huge Alphabet Bet—Should You Follow?
- Michael Burry Is Betting Against Palantir Again—Should Investors Care?
- Fabrinet’s Sell-Off May Prove It Is One of AI’s Most Misunderstood Stocks
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
